Total Payments
$13,565
2024 Payments
$3,732
Companies
40
Transactions
759
Medicare Patients
1,992
Medicare Billing
$204,487
Payment Breakdown by Category
Food & Beverage$13,496 (99.5%)
Education$69.93 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,496 | 748 | 99.5% |
| Education | $69.93 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,200 | 188 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,648 | 114 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,034 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $864.28 | 42 | $0 (2024) |
| PFIZER INC. | $599.18 | 31 | $0 (2024) |
| GENZYME CORPORATION | $578.07 | 23 | $0 (2024) |
| Amgen Inc. | $490.69 | 25 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $442.79 | 22 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $420.07 | 21 | $0 (2024) |
| QOL Medical, LLC | $394.75 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,732 | 197 | ABBVIE INC. ($651.67) |
| 2023 | $3,783 | 212 | ABBVIE INC. ($737.64) |
| 2022 | $3,316 | 190 | ABBVIE INC. ($1,061) |
| 2021 | $2,734 | 160 | AbbVie Inc. ($749.47) |
All Payment Transactions
759 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/17/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Genetic Disease | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Immunology | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.63 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Rare Disease | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $12.45 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/02/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 607 | 1,428 | $302,284 | $74,941 |
| 2022 | 6 | 473 | 565 | $167,003 | $45,344 |
| 2021 | 7 | 502 | 20,109 | $160,072 | $56,517 |
| 2020 | 6 | 410 | 466 | $97,851 | $27,685 |
Total Patients
1,992
Total Services
22,568
Medicare Billing
$204,487
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 294 | 391 | $136,068 | $32,884 | 24.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 724 | $37,004 | $13,693 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $49,322 | $9,847 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 63 | $29,673 | $7,203 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 73 | $17,301 | $4,517 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $12,530 | $2,416 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $10,260 | $2,193 | 21.4% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 13 | 14 | $8,344 | $1,976 | 23.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 22 | $1,782 | $212.31 | 11.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 241 | 318 | $93,240 | $26,665 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 108 | $24,468 | $7,048 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $21,538 | $4,698 | 21.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 53 | 53 | $10,010 | $2,590 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 18 | $8,115 | $2,220 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $9,632 | $2,123 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 227 | 290 | $75,490 | $26,241 | 34.8% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 15 | 19,500 | $39,780 | $17,313 | 43.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 173 | 173 | $27,680 | $8,194 | 29.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 50 | $8,810 | $2,625 | 29.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 15 | 26 | $4,108 | $1,441 | 35.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 16 | $1,504 | $672.64 | 44.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2021 | 16 | 54 | $2,700 | $29.58 | 1.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 141 | 173 | $44,980 | $12,790 | 28.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 134 | 153 | $26,975 | $7,874 | 29.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 71 | 71 | $18,460 | $4,714 | 25.5% |
About Brittany Dickert, FNP
Brittany Dickert, FNP is a Family healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1598165474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brittany Dickert, FNP has received a total of $13,565 in payments from pharmaceutical and medical device companies, with $3,732 received in 2024. These payments were reported across 759 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($13,496).
As a Medicare-enrolled provider, Dickert has provided services to 1,992 Medicare beneficiaries, totaling 22,568 services with total Medicare billing of $204,487. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Annapolis, MD
- Active Since 08/28/2014
- Last Updated 10/13/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1598165474
Products in Payments
- XIFAXAN (Drug) $1,335
- DUPIXENT (Biological) $1,021
- RINVOQ (Biological) $933.30
- ENTYVIO (Biological) $768.84
- HUMIRA (Biological) $665.44
- XELJANZ (Drug) $568.88
- STELARA (Biological) $516.58
- OCALIVA (Drug) $420.07
- LINZESS (Drug) $418.52
- ZEPOSIA (Drug) $356.34
- SKYRIZI (Biological) $345.97
- AVSOLA (Biological) $334.09
- CREON (Drug) $329.10
- DIFICID (Drug) $322.42
- IBSRELA (Drug) $320.46
- SUCRAID (Drug) $286.95
- VIBERZI (Drug) $261.32
- MAVYRET (Drug) $246.21
- REMICADE (Biological) $227.02
- TRULANCE (Drug) $219.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Annapolis
Mrs. Elisse Gray, Crnp, CRNP
Family — Payments: $13,935
Family $13,935
Mrs. Moncheri Adebayo, Crnp, CRNP
Family — Payments: $9,626
Family $9,626
Mrs. Katie Creighton, Np-C, NP-C
Family — Payments: $7,434
Family $7,434
Tanya Lee, Fnp, FNP
Family — Payments: $5,018
Family $5,018
Danielle Goldberg, C.r.n.p, C.R.N.P
Family — Payments: $4,953
Family $4,953
Lisa Medeiros, Crnp, CRNP
Family — Payments: $4,723
Family $4,723